Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 15051-15100 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT03955978
TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer
PHASE1Active, not recruiting
10 participants
Started: Oct 15, 2019 · Completed: Dec 18, 2025
2 conditions2 sponsors1 location
NCT04084548
Perioperative Lidocaine and Ketamine in Abdominal Surgery
PHASE3Active, not recruiting
420 participants
Started: Oct 15, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04165694
Single Anastomosis Duodenal Ileal Bypass (SADI) for Sleeve Revision
NAActive, not recruiting
54 participants
Started: Oct 15, 2019 · Completed: Dec 31, 2030
2 conditions1 sponsor1 location
NCT04116437
Zanubrutinib (BGB-3111) in Participants With Previously Treated B-Cell Lymphoma Intolerant of Prior Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment
PHASE2Active, not recruiting
90 participants
Started: Oct 15, 2019 · Completed: Oct 31, 2025
4 conditions1 sponsor24 locations
NCT03636243
Comparative Evaluation of the Evolution of Arterial and Microcirculatory Endothelial Function in Obese Patients With Type-2 Diabetes Versus Non-diabetic Obese Patients After a First Bariatric Surgery
NAActive, not recruiting
37 participants
Started: Oct 15, 2019 · Completed: Sep 30, 2025
3 conditions1 sponsor1 location
NCT03860792
Therapeutic Diets in Alzheimer's Disease
NAActive, not recruiting
80 participants
Started: Oct 15, 2019 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT04040764
Uncemented Tritanium TKR vs Cemented Triathlon TKR
NAActive, not recruiting
60 participants
Started: Oct 15, 2019 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT04070703
Tai Ji Quan and Cognitive Function in Older Adults With Mild Cognitive Impairment
NAActive, not recruiting
318 participants
Started: Oct 15, 2019 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT03964727
Study of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors
PHASE2Active, not recruiting
227 participants
Started: Oct 15, 2019 · Completed: Dec 31, 2025
1 condition1 sponsor65 locations
NCT04017468
Suprafascial Vancomycin Powder for Prevention of Surgical Site Infections After Instrumented Posterior Spinal Fusion
PHASE2Active, not recruiting
450 participants
Started: Oct 15, 2019 · Completed: Mar 31, 2027
1 condition2 sponsors7 locations
NCT04391114
Top-Down Holmium Laser Enucleation of the Prostate (HoLEP) vs the Traditional HoLEP for Treatment of Benign Prostatic Hyperplasia (BPH)
NAActive, not recruiting
107 participants
Started: Oct 15, 2019 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT03970603
Syndesmosis Ankle Study
NAActive, not recruiting
40 participants
Started: Oct 15, 2019 · Completed: Jun 30, 2025
2 conditions1 sponsor1 location
NCT03914547
Home Video-based Telemedicine to Reduce Hypoglycemia Fear in Parents of Young Children
NAActive, not recruiting
396 participants
Started: Oct 15, 2019 · Completed: Mar 31, 2026
1 condition4 sponsors2 locations
NCT04630431
Understanding Challenges, Behavioral Patterns, and Preferences Toward Participation in Clinical Trials in Minority Patient Populations: Development of a Personalized Clinical Trial Educational Platform to Increase Participation in Clinical Trials Among Underserved Cancer Patients
NAActive, not recruiting
590 participants
Started: Oct 15, 2019 · Completed: Oct 15, 2026
2 conditions1 sponsor3 locations
NCT03983993
Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer
PHASE2Active, not recruiting
26 participants
Started: Oct 15, 2019 · Completed: Oct 31, 2025
6 conditions4 sponsors3 locations
NCT03956537
PMCF Neo Pedicle Screw and Cage Systems
N/AActive, not recruiting
150 participants
Started: Oct 15, 2019 · Completed: Oct 31, 2028
6 conditions2 sponsors2 locations
NCT04281134
Development of Adaptive Deep Brain Stimulation for OCD
NAActive, not recruiting
3 participants
Started: Oct 11, 2019 · Completed: Jun 30, 2026
1 condition6 sponsors3 locations
NCT03917238
Beta Cell Imaging During and Shortly After the Honeymoon Phase of T1D
NAActive, not recruiting
14 participants
Started: Oct 11, 2019 · Completed: Dec 25, 2026
1 condition1 sponsor2 locations
NCT04049513
ENABLE-1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy)
PHASE1Active, not recruiting
30 participants
Started: Oct 11, 2019 · Completed: Mar 31, 2029
6 conditions2 sponsors1 location
NCT03863184
Acalabrutinib-Lenalidomide-Rituximab in Patients With Untreated MCL
PHASE2Active, not recruiting
37 participants
Started: Oct 11, 2019 · Completed: Sep 30, 2027
1 condition3 sponsors1 location
NCT04126005
Natural History Study of Patients With Canavan Disease (CANinform Study)
N/AActive, not recruiting
70 participants
Started: Oct 10, 2019 · Completed: Jul 31, 2025
1 condition1 sponsor3 locations
NCT03896646
Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D)
NAActive, not recruiting
42 participants
Started: Oct 10, 2019 · Completed: Sep 30, 2026
7 conditions2 sponsors1 location
NCT03910075
Perinatal Arterial Stroke: A Multi-site RCT of Intensive Infant Rehabilitation (I-ACQUIRE)
PHASE3Active, not recruiting
216 participants
Started: Oct 10, 2019 · Completed: May 1, 2026
2 conditions6 sponsors15 locations
NCT03961854
Lactobacillus Johnsonii in Children and Adolescents With T1D
PHASE2Active, not recruiting
30 participants
Started: Oct 10, 2019 · Completed: Mar 11, 2026
1 condition2 sponsors1 location
NCT03934840
CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone
PHASE2Active, not recruiting
22 participants
Started: Oct 10, 2019 · Completed: May 31, 2025
1 condition1 sponsor8 locations
NCT03952585
De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer
PHASE2/PHASE3Active, not recruiting
384 participants
Started: Oct 9, 2019 · Completed: Dec 11, 2025
8 conditions2 sponsors494 locations
NCT04153539
Acute Health Effects of Traffic-Related Air Pollution Exposure
NAActive, not recruiting
69 participants
Started: Oct 9, 2019 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT03730649
Effect of Topical Sulforaphane on Skin Aging and With Ultraviolet and Visible Light Exposure
EARLY_PHASE1Active, not recruiting
12 participants
Started: Oct 9, 2019 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT04048941
One Needle Hand Acupuncture for MSK Disorders
NAActive, not recruiting
120 participants
Started: Oct 8, 2019 · Completed: Dec 1, 2025
3 conditions1 sponsor1 location
NCT04083430
Cytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D Vaccination
PHASE4Active, not recruiting
60 participants
Started: Oct 8, 2019 · Completed: Dec 15, 2025
3 conditions1 sponsor1 location
NCT04050436
Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer
PHASE2Active, not recruiting
231 participants
Started: Oct 8, 2019 · Completed: Sep 30, 2025
3 conditions2 sponsors56 locations
NCT04602091
Observational Study in Patients Treated With JAK Inhibitors for Inflammatory Rheumatism (MAJIK)
N/AActive, not recruiting
2,300 participants
Started: Oct 8, 2019 · Completed: Jun 30, 2030
4 conditions2 sponsors60 locations
NCT03953300
Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics
PHASE4Active, not recruiting
74 participants
Started: Oct 8, 2019 · Completed: Sep 9, 2026
1 condition1 sponsor35 locations
NCT04037254
Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring
PHASE1/PHASE2Active, not recruiting
22 participants
Started: Oct 8, 2019 · Completed: Sep 26, 2025
7 conditions2 sponsors95 locations
NCT03833440
Precision Immuno-Oncology for Advanced Non-small Cell Lung Cancer Patients With PD-1 ICI Resistance
PHASE2Active, not recruiting
114 participants
Started: Oct 8, 2019 · Completed: Feb 28, 2025
1 condition1 sponsor1 location
NCT04010955
Adding Antiplatelet During Edoxaban Treatment in Stroke Patients With Non-valvular Atrial Fibrillation (ADD-ON)
N/AActive, not recruiting
1,200 participants
Started: Oct 8, 2019 · Completed: Jun 27, 2026
8 conditions15 sponsors1 location
NCT04131166
Precision Nutrition and Metabolic Function
NAActive, not recruiting
300 participants
Started: Oct 8, 2019 · Completed: Dec 31, 2029
2 conditions2 sponsors1 location
NCT03474692
Virta Health Registry
N/AActive, not recruiting
50,000 participants
Started: Oct 7, 2019 · Completed: Oct 31, 2039
5 conditions1 sponsor1 location
NCT03892655
Real World Study of Biosimilar Trastuzumab in Her2 Positive Breast Cancer
N/AActive, not recruiting
170 participants
Started: Oct 7, 2019 · Completed: Jul 31, 2028
1 condition1 sponsor22 locations
NCT03910972
Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults
PHASE1/PHASE2Active, not recruiting
290 participants
Started: Oct 7, 2019 · Completed: Sep 30, 2025
2 conditions3 sponsors1 location
NCT04126200
Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
PHASE2Active, not recruiting
209 participants
Started: Oct 7, 2019 · Completed: Feb 12, 2029
1 condition1 sponsor40 locations
NCT04123626
A Study to Evaluate the Safety and Tolerability of QR-1123 in Subjects With Autosomal Dominant Retinitis Pigmentosa Due to the P23H Mutation in the RHO Gene
PHASE1/PHASE2Active, not recruiting
11 participants
Started: Oct 7, 2019 · Completed: Jun 7, 2022
8 conditions1 sponsor5 locations
NCT03983512
PULSTA Transcatheter Pulmonary Valve Pre-Approval Study
NAActive, not recruiting
58 participants
Started: Oct 7, 2019 · Completed: Dec 31, 2026
4 conditions2 sponsors11 locations
NCT04016246
Respiratory Effect of the LISA Method with Sedation by Propofol Versus Absence of Sedation.
PHASE3Active, not recruiting
233 participants
Started: Oct 7, 2019 · Completed: Oct 31, 2026
1 condition1 sponsor13 locations
NCT03529422
Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN
PHASE2Active, not recruiting
18 participants
Started: Oct 7, 2019 · Completed: May 6, 2026
4 conditions2 sponsors3 locations
NCT03962166
Characterizing Patients With POAF in Relation to Cardiac Surgery by wavECG and TTE
N/AActive, not recruiting
353 participants
Started: Oct 7, 2019 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT04100200
Berries, Inflammation, and Gut Microbiome
NAActive, not recruiting
105 participants
Started: Oct 7, 2019 · Completed: Jan 1, 2026
2 conditions2 sponsors1 location
NCT04082897
ObinutuzuMab AtezOlizumab and VenetocLax in RichTer transfOrmation
PHASE2Active, not recruiting
28 participants
Started: Oct 4, 2019 · Completed: Dec 31, 2026
1 condition1 sponsor17 locations
NCT04007029
Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia
PHASE1Active, not recruiting
24 participants
Started: Oct 4, 2019 · Completed: Aug 1, 2027
14 conditions2 sponsors1 location
NCT04236882
Sleep and Physical Activity Intervention for Increasing Physical Activity in Overweight or Obese and Sedentary African Americans
NAActive, not recruiting
28 participants
Started: Oct 4, 2019 · Completed: Apr 30, 2030
2 conditions2 sponsors2 locations